Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.
A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Other | EGFR mutation testing |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Testing for mutation status | Procedure | EGFR mutation test |
|
| Measure | Description | Time Frame |
|---|---|---|
| EGFR mutation status of Asian patients with advanced NSCLC | Samples will be tested after informed consent. Mutation results will be available within 1-3 weeks. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guy Yeoman, MBBS, MFPM | AstraZeneca | Study Director |
| Robin Meng, MD, PhD | AstraZeneca Taiwan | Study Chair |
| Yang Pan-Chyr, MD, PhD | National Taiwan University College of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Beijing | Beijing Municipality | China | |||
| Research Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Guangzhou |
| Guangdong |
| China |
| Research Site | Shijiazhuang | Hebei | China |
| Research Site | Zhengzhou | Henan | China |
| Research Site | Wuhan | Hubei | China |
| Research Site | Changchun | Jilin | China |
| Research Site | Shenyang | Liaoning | China |
| Research Site | Jinan | Shandong | China |
| Research Site | Shanghai | Shanghai Municipality | China |
| Research Site | Taiyuan | Shanxi | China |
| Research Site | Chengdu | Sichuan | China |
| Research Site | Tianjin | Tianjin Municipality | China |
| Research Site | Hong Kong | Hong Kong | Hong Kong |
| Research Site | Chennai | Chennai | India |
| Research Site | Vadodara | Gujarat | India |
| Research Site | Kochi | Kerala | India |
| Research Site | Kolkata | Kolkata | India |
| Research Site | Mumbai | Maharashtra | India |
| Research Site | Pune | Maharashtra | India |
| Research Site | Rohini | National Capital Territory of Delhi | India |
| Research Site | Cebu City | Philippines |
| Research Site | City of Taguig | Philippines |
| Research Site | Manila | Philippines |
| Research Site | Pasay | Philippines |
| Research Site | Quezon City | Philippines |
| Research Site | Chiayi City | Taiwan |
| Research Site | Kaohsiung City | Taiwan |
| Research Site | Taichung | Taiwan |
| Research Site | Tainan | Taiwan |
| Research Site | Taipei | Taiwan |
| Research Site | Taoyuan | Taiwan |
| Research Site | Bangkok | Bangkok | Thailand |
| Research Site | Songkhla | Changwat Songkhla | Thailand |
| Research Site | Chiang Mai | Chiang Mai | Thailand |
| Research Site | Hanoi | Vietnam |
| Research Site | Ho Chi Minh City | Vietnam |
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided